The pharmacological induction of HO-1 is associated with the inhibition of inducible nitric oxide synthase activity and the reduction of intestinal injury.[37] These experiments indicate that Gln benefits colitis and exerts regulatory effects through different mechanisms. Here, HMOX1 is linked to colitis.